A study published in the European Medical Journal involving nearly 3,000 participants found that nebulisers are predominantly used by patients with advanced chronic obstructive pulmonary disease (COPD). The research revealed that nearly 50% of patients with severe COPD relied on nebulisers, which are often used reactively during exacerbations rather than as a routine early treatment. The findings indicate a strong link between nebuliser use and disease severity, with patients experiencing frequent flare-ups and lower lung function more likely to depend on nebulised therapy. Interestingly, long-acting nebulised medications were rarely utilized, raising questions about treatment optimization. For patients, frequent nebuliser use may signal advanced disease, necessitating a review of treatment plans. This underscores the importance of early diagnosis and consistent management to mitigate disease progression and reduce reliance on emergency therapies.